Breaking News

Tweet TWEET

MyMedicalRecords Files Complaint Against WebMD for Infringement of Two U.S. Patents

MyMedicalRecords Files Complaint Against WebMD for Infringement of Two U.S. 
Patents 
LOS ANGELES, CA -- (Marketwired) -- 10/03/13 --  MyMedicalRecords,
Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF)
(collectively, "MMR"), today announced the filing of a complaint for
infringement of two of MMR's U.S. patents against WebMD Health Corp.
and WebMD Health Services Group, Inc. (collectively "WebMD"). The
complaint was filed yesterday in United States District Court for the
Central District of California, case number CV13-7285 (CAS/ASx). The
complaint alleges that WebMD is infringing on two of MMR's Personal
Health Records (PHR) patents, specifically U.S. Patent No. 8,301,466
(the '466 Patent) and U.S. Patent No. 8,498,883 (the '883 Patent),
and as a result, MMR is seeking monetary damages as well as a
permanent injunction.  
Pursuant to a written agreement announced June 7, 2013, MMR dismissed
a patent infringement complaint against WebMD it had filed on
February 11, 2013 (the "Original Complaint"). The purpose of the
written agreement was to allow MMR and WebMD to continue months of
effort trying to resolve the matter without the timing constraints
imposed by a lawsuit. As the dismissal was without prejudice, MMR
retained the right to re-file the litigation at any time, which MMR
has now decided to do.  
On July 30, 2013, MMR received an additional patent, the '883 Patent
entitled "Method for Providing a User with a Service for Accessing
and Collecting Prescriptions." Since the Original Complaint was not
resolved, as stated above, MMR elected to file the current complaint
and include both the '466 Patent and the '883 Patent.  
The complaint alleges that WebMD has and continues to directly
infringe on features and functionality that are the subject of MMR's
patents by making, using or offering for sale, and/or selling certain
methods or systems disclosed and claimed in both the '466 Patent and
the '883 Patent. The complaint also alleges that WebMD provides
health information services to consumers and healthcare providers, as
well as employers and health plans through both their private and
public portals; and provides a user with the ability to access and
collect personal health records and an ability to access, collect,
and/or manag
e drug prescriptions associated with the user in a secure
and private manner. 
MMR is a leading provider of Personal Health Records,
MyEsafeDepositBox storage solutions, and MMRPro document management
and imaging systems for healthcare professionals. The MMR Patent
Portfolio includes eight issued U.S. patents as well as additional
applications and continuation applications totaling hundreds of
claims. MMR also has been granted patents and/or has other pending
applications in countries of commercial interest including Australia,
Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China,
South Korea, Israel, and European nations. The patents involve
inventions pertaining to Personal Health Records, Patient Portals and
other Electronic Health Record systems. 
MMR continues to pursue efforts to monetize its patent portfolio and
other IP by investigating potential infringement of MMR's patents by
entities such as retail pharmacies, EHR and PHR vendors, laboratory
systems, and healthcare professionals. For additional information
regarding the MyMedicalRecords, Inc. complaint against WebMD, contact
Ted Ward at Liner Grode Stein Yankelevitz Sunshine Regenstreif &
Taylor LLP at (310) 500-3384. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients through an integrated patient portal.
Through its merger with Favrille, Inc. in January 2009, the Company
acquired intellectual property biotech assets that include anti-CD20
antibodies and data and samples from its FavId(TM)/Specifid(TM)
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit
www.mmrglobal.com. View demos and video tutorials of MMR's products
and services at www.mmrtheater.com. 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements. Some
can be identified by the use of words (and their derivations) such as
"need," "possibility," "potential," "intend," "offer," "development,"
"if," "negotiate," "when," "begun," "believe," "achieve," "will,"
"estimate," "expect," "maintain," "plan," and "continue," or the
negative of these words. Actual outcomes and results of operations
and the timing of selected events may differ materially from the
results predicted, and any reported results should not be considered
as an indication of future performance. Such statements are
necessarily based on assumptions and estimates and are subject to
various risks and uncertainties, including those relating to the
possible invalidity of the underlying assumptions and estimates and
possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and actions
taken or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such differences
include, but are not limited to: unexpected outcomes with respect to
intellectual property enforcement actions, claims of intellectual
property infringement and general intellectual property litigation;
our ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community 
and consumer retail market; business prospects,
results of operations or financial condition; risks related to the
current uncertainty and instability in financial and lending markets,
including global economic uncertainties; the timing and volume of
sales and installations; the length of sales cycles and the
installation process; the market's acceptance of new product and
service introductions; competitive product offerings and promotions;
changes in government laws and regulations including the 2009 HITECH
Act and changes in Meaningful Use and the 2010 Affordable Care Act;
future changes in tax legislation and initiatives in the healthcare
industry; undetected errors in our products; the possibility of
interruption at our data centers; risks related to third party
vendors; risks related to obtaining and integrating third-party
licensed technology; risks related to a security breach by third
parties; risks associated with recruitment and retention of key
personnel; other litigation matters; uncertainties associated with
doing business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of the date
of this release and, except as required by applicable law, does not
undertake any obligation to update any forward-looking statements
contained in this release as a result of new information, future
events or otherwise.  
CONTACT: 
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033 
 
 
Press spacebar to pause and continue. Press esc to stop.